Akcea Therapeutics Inc (NASDAQ: AKCA), a subsidiary of Ionis Pharmaceuticals Inc (NASDAQ: IONS), has named Tracy Palmer Berns as its new chief compliance officer, it was reported on Monday.
In the new role, Berns is to manage the firm's ongoing compliance program aimed at policy development and training. In collaboration with other members of the team, Berns is to provide strategic counsel regarding development of business goals and compliance matters related to Akcea's commercial products and investigational therapies.
Prior to joining Akcea, Berns served as vice president, chief compliance officer and legal affairs at AMAG Pharmaceuticals Inc. She has also held various positions at Medtronic and as a regulatory manager of the EP division at CR Bard, regulatory affairs manager and staff attorney at ABIOMED, senior consultant at EXPERTech and associate general counsel at Thermo Electron Corporation.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation